DGAM
MGRX icon

Desjardins Global Asset Management’s Mangoceuticals MGRX Stock Holding History

Desjardins Global Asset Management’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8
Closed -$25.1K – 683
2023
Q3 		$25.1K Buy
+8
New +$150 ﹤0.01% 591

Other funds holding MGRX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
VCWA
Vanguard Capital Wealth Advisors Denver, Colorado $108M AUM 50.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Desjardins Global Asset Management's MGRX Position: Q4 2023 in Review

Desjardins Global Asset Management sold out of Mangoceuticals (MGRX) in Q4 2023, closing a stake of 8 shares — an estimated $25.1K sold.

Desjardins Global Asset Management first reported a position in MGRX in Q3 2023 and held it in 1 quarter. The position peaked at $25.1K in Q3 2023. 5 funds tracked by Wall St. Rank hold MGRX as of Q4 2023.

  • Desjardins Global Asset Management reported no remaining Mangoceuticals position as of Q4 2023 after selling out during the quarter.
  • Desjardins Global Asset Management sold 8 Mangoceuticals shares in Q4 2023, an estimated $25.1K.
  • Desjardins Global Asset Management first reported a position in Mangoceuticals in Q3 2023 and held it in 1 quarter.
  • Desjardins Global Asset Management's Mangoceuticals position peaked at $25.1K in Q3 2023.
  • 5 funds tracked by Wall St. Rank held Mangoceuticals as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.